External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home ASOPRS 2025
Roche and Genentech at

ASOPRS 2025

October 16 - October 17
Orlando, USA
asoprs.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
05:07 PM
Duration 6mins Orlando
Primary Results of the Phase 3 SatraGO-1 and Satra-GO-2 Trials: Efficacy and Safety of Satralizumab▼ in Thyroid Eye Disease
Cesar Briceno, Idowu O, Brockwell L, Kuenzel T, Burdeska A, Brittain C, Barteselli G, Ortiz-Perez S
Ophthalmology | Thyroid eye disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.